ESC 365 - Novel weight loss drugs: how much cardiovascular risk reduction can we achieve?

Open Access

Novel weight loss drugs: how much cardiovascular risk reduction can we achieve?

Session: Lose some weight and reduce your cardiovascular risk: is it really that simple?

Topic: Obesity

Speaker: Mrs M. Snaterse-Zuidam (Amsterdam, NL)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Mrs Marjolein Snaterse-Zuidam

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

1 presentation

1 follower

3 more presentations in this session

Weight loss in obese people with diabetes: metabolic and inflammatory changes

Speaker: Professor A. Pfeiffer (Berlin, DE)

What is more relevant in cardiovascular disease: losing weight or improving fitness?

Speaker: Doctor M. Carnethon (Chicago, US)

Long-term maintenance of weight loss: what works in practice?

Speaker: Doctor M. Bahls (Greifswald, DE)

Access the full session

Lose some weight and reduce your cardiovascular risk: is it really that simple?

Speakers: Mrs M. Snaterse-Zuidam, Professor A. Pfeiffer, Doctor M. Carnethon, Doctor M. Bahls

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources